{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:28:16Z","timestamp":1792297696832,"version":"4.4.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2008,12,12]],"date-time":"2008-12-12T00:00:00Z","timestamp":1229040000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s10620-008-0613-3","type":"journal-article","created":{"date-parts":[[2008,12,11]],"date-time":"2008-12-11T21:13:09Z","timestamp":1229029989000},"page":"2242-2246","source":"Crossref","is-referenced-by-count":37,"title":["Modafinil in the Treatment of Debilitating Fatigue in Primary Biliary Cirrhosis: A Clinical Experience"],"prefix":"10.1007","volume":"54","author":[{"given":"S.","family":"Ian Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"de Jongh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall M.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,12,12]]},"reference":[{"issue":"12","key":"613_CR1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","volume":"353","author":"MM Kaplan","year":"2005","unstructured":"Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med. 2005;353(12):1261\u20131273.","journal-title":"N Engl J Med"},{"key":"613_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-230X-5-11","volume":"5","author":"PC Borg","year":"2005","unstructured":"Borg PC, Fekkes D, Vrolijk JM, van Buuren HR. The relation between plasma tyrosine concentration and fatigue in primary biliary cirrhosis and primary sclerosing cholangitis. BMC Gastroenterol. 2005;5:11.","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"613_CR3","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S1089-3261(03)00105-3","volume":"7","author":"NV Bergasa","year":"2003","unstructured":"Bergasa NV. Pruritus and fatigue in primary biliary cirrhosis. Clin Liver Dis. 2003;7(4):879\u2013900.","journal-title":"Clin Liver Dis"},{"issue":"4\u20135","key":"613_CR4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.neuint.2007.06.002","volume":"52","author":"S Ahboucha","year":"2008","unstructured":"Ahboucha S, Pomier-Layrargues G, Vincent C, et al. Reduced plasma dehydroepiandrosterone sulfate levels are significantly correlated with fatigue severity in patients with primary biliary cirrhosis. Neurochem Int. 2008;52(4\u20135):569\u2013574.","journal-title":"Neurochem Int"},{"issue":"6","key":"613_CR5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/00042737-199906000-00007","volume":"11","author":"EA Jones","year":"1999","unstructured":"Jones EA, Bergasa NV. The pathogenesis and treatment of pruritus and fatigue in patients with PBC. Eur J Gastroenterol Hepatol. 1999;11(6):623\u2013631.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"613_CR6","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1111\/j.1572-0241.2007.01235.x","volume":"102","author":"Y Gong","year":"2007","unstructured":"Gong Y, Huang Z, Christensen E, Gluud C. Ursodeoxycholic acid for patients with primary biliary cirrhosis: an updated systematic review and meta-analysis of randomized clinical trials using Bayesian approach as sensitivity analyses. Am J Gastroenterol. 2007;102(8):1799\u20131807.","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"613_CR7","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s10620-006-9397-5","volume":"51","author":"JA Talwalkar","year":"2006","unstructured":"Talwalkar JA, Donlinger JJ, Gossard AA, Keach JC, Jorgensen RA, Lindor KD. Fluoxetine for the treatment of fatigue in primary biliary cirrhosis: a randomized, double-blind controlled trial. Dig Dis Sci. 2006;51(11):1985\u20131991.","journal-title":"Dig Dis Sci"},{"key":"613_CR8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-230X-4-13","volume":"4","author":"PC Borg","year":"2004","unstructured":"Borg PC, van Os E, van den Broek WW, Hansen BE. Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a randomised controlled trial. BMC Gastroenterol. 2004;4:13.","journal-title":"BMC Gastroenterol"},{"issue":"9","key":"613_CR9","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1046\/j.1365-2036.2001.01018.x","volume":"15","author":"PM Battezzati","year":"2001","unstructured":"Battezzati PM, Zuin M, Crosignani A, et al. Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients. Aliment Pharmacol Ther. 2001;15(9):1427\u20131434.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"613_CR10","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1365-2036.2006.03048.x","volume":"24","author":"MA Babatin","year":"2006","unstructured":"Babatin MA, Sanai FM, Swain MG. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy. Aliment Pharmacol Ther. 2006;24(5):813\u2013820.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"613_CR11","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/hep.20698","volume":"41","author":"JJ Theal","year":"2005","unstructured":"Theal JJ, Toosi MN, Girlan L, et al. A randomized, controlled crossover trial of ondansetron in patients with primary biliary cirrhosis and fatigue. Hepatology. 2005;41(6):1305\u20131312.","journal-title":"Hepatology"},{"issue":"5","key":"613_CR12","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0016-5085(99)70403-8","volume":"117","author":"MM Kaplan","year":"1999","unstructured":"Kaplan MM, Schmid C, Provenzale D, Sharma A, Dickstein G, McKusick A. A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis. Gastroenterology. 1999;117(5):1173\u20131180.","journal-title":"Gastroenterology"},{"issue":"7","key":"613_CR13","doi-asserted-by":"crossref","first-page":"546","DOI":"10.7326\/0003-4819-143-7-200510040-00024","volume":"143","author":"MM Kaplan","year":"2005","unstructured":"Kaplan MM, Bonis PA. Modafinil for the treatment of fatigue in primary biliary cirrhosis. Ann Intern Med. 2005;143(7):546\u2013547.","journal-title":"Ann Intern Med"},{"issue":"4","key":"613_CR14","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2036.2006.03223.x","volume":"25","author":"DE Jones","year":"2007","unstructured":"Jones DE, Newton JL. An open study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis. Aliment Pharmacol Ther. 2007;25(4):471\u2013476.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"613_CR15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/hep.21230","volume":"44","author":"JL Newton","year":"2006","unstructured":"Newton JL, Gibson GJ, Tomlinson M, Wilton K, Jones D. Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence. Hepatology. 2006;44(1):91\u201398.","journal-title":"Hepatology"},{"issue":"1","key":"613_CR16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1517\/13543784.7.1.99","volume":"7","author":"TE Scammell","year":"1998","unstructured":"Scammell TE, Matheson J. Modafinil: a novel stimulant for the treatment of narcolepsy. Expert Opin Investig Drugs. 1998;7(1):99\u2013112.","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"613_CR17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/026988110001400107","volume":"14","author":"DR Jasinski","year":"2000","unstructured":"Jasinski DR. An evaluation of the abuse potential of modafinil using methylphenidate as a reference. J Psychopharmacol. 2000;14(1):53\u201360.","journal-title":"J Psychopharmacol"},{"issue":"2","key":"613_CR18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00008877-200203000-00002","volume":"13","author":"CR Rush","year":"2002","unstructured":"Rush CR, Kelly TH, Hays LR, Baker RW, Wooten AF. Acute behavioral and physiological effects of modafinil in drug abusers. Behav Pharmacol. 2002;13(2):105\u2013115.","journal-title":"Behav Pharmacol"},{"issue":"3","key":"613_CR19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00002826-200005000-00004","volume":"23","author":"DR Jasinski","year":"2000","unstructured":"Jasinski DR, Kovacevi\u0107-Ristanovi\u0107 R. Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy. Clin Neuropharmacol. 2000;23(3):149\u2013156.","journal-title":"Clin Neuropharmacol"},{"key":"613_CR20","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/sj.npp.1301534","volume":"33","author":"MJ Minzenberg","year":"2007","unstructured":"Minzenberg MJ, Carter CS. Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology. 2007;33:1477\u20131502.","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"613_CR21","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00002826-200309000-00009","volume":"26","author":"JR Schwartz","year":"2003","unstructured":"Schwartz JR, Feldman NT, Bogan RK, Nelson MT, Hughes RJ. Dosing regimen effects of modafinil for improving daytime wakefulness in patients with narcolepsy. Clin Neuropharmacol. 2003;26(5):252\u2013257.","journal-title":"Clin Neuropharmacol"},{"issue":"5","key":"613_CR22","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa041292","volume":"353","author":"CA Czeisler","year":"2005","unstructured":"Czeisler CA, Walsh JK, Roth T, et al. US Modafinal in shift work sleep disorder associated with shift-work sleep disorder. N Engl J Med. 2005;353(5):476\u2013486.","journal-title":"N Engl J Med"},{"issue":"4","key":"613_CR23","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/sleep\/28.4.464","volume":"28","author":"JE Black","year":"2005","unstructured":"Black JE, Hirshkowitz M. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea\/hypopnea syndrome. Sleep. 2005;28(4):464\u2013471.","journal-title":"Sleep"},{"issue":"7","key":"613_CR24","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1212\/01.WNL.0000158272.27070.6A","volume":"64","author":"B Stankoff","year":"2005","unstructured":"Stankoff B, Waubant E, Confavreux C, et al. Modafinil for fatigue in MS; a randomized placebo-controlled double-blind study. Neurology. 2005;64(7):1139\u20131143.","journal-title":"Neurology"},{"issue":"12","key":"613_CR25","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/jnnp.2005.065870","volume":"76","author":"WG Ondo","year":"2005","unstructured":"Ondo WG, Fayle R, Atassi F, Jankovic J. Modafinil for daytime somnolence in Parkinson\u2019s disease: double blind, placebo controlled parallel trial. J Neurol Neurosurg Psychiatr. 2005;76(12):1636\u20131639.","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"2","key":"613_CR26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1017\/S1092852900010622","volume":"11","author":"ME Thase","year":"2006","unstructured":"Thase ME, Fava M, De Battista C, Arora S, Hughes RJ. Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study. CNS Spectr. 2006;11(2):93\u2013102.","journal-title":"CNS Spectr"},{"key":"613_CR27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1176\/appi.neuropsych.17.3.405","volume":"17","author":"JR Schwartz","year":"2005","unstructured":"Schwartz JR, Feldman NT. Dose effects of modafinil in sustaining wakefulness in narcolepsy patients with residual evening sleepiness. J Neuropsychiatry Clin Neurosci. 2005;17:405\u2013412.","journal-title":"J Neuropsychiatry Clin Neurosci"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-008-0613-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-008-0613-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-008-0613-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T19:42:44Z","timestamp":1559245364000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-008-0613-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,12]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["613"],"URL":"https:\/\/doi.org\/10.1007\/s10620-008-0613-3","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,12]]}}}